The effect of linomide on the migration and the proliferation of capillary endothelial cells elicited by vascular endothelial growth factor

British Journal of Pharmacology

Volumn 119, Issue 4, 1996, Pages 619-621

  Parenti, Astrid ^a   Donnini, Sandra ^a   Morbidelli, Lucia ^a   Granger, Harris J ^b   Ziche, Marina ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

Author keywords

Antiangiogenesis; Capillary endothelial cells; Linomide; Migration; Proliferation; Vascular endothelial growth factor

Indexed keywords

QUINOLINE DERIVATIVE; ROQUINIMEX; VASCULOTROPIN;

ANGIOGENESIS; ARTICLE; CAPILLARY ENDOTHELIUM; CELL MIGRATION; CELL PROLIFERATION; DRUG MECHANISM; ENDOTHELIUM CELL; GROWTH INHIBITION; PRIORITY JOURNAL;

EID: 0029952950     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1476-5381.1996.tb15718.x     Document Type: Article

References (9)

1. FERRARA, N., HOUK, K.A., JAKEMAN, L.B. & LEUNG, D.W. (1993). Molecular and biological properties of the vascular endothelial growth factor family of proteins. Endocrinol. Rev., 13, 18-32.
2. FOLKMAN, J. (1995). Clinical application of research on angiogenesis. New Engl. J. Med., 333, 1757-1763.
3. KALLAND, T., ALM, G. & STAHHANDSKE, T. (1985). Augmentation of mouse natural killer cell activity by LS-2616, a new immunomodulator. J. Immunol., 134, 3956-3961.
4. MORBIDELLI, L., CHANG, C.-H., DOUGLAS, J.G., GRANGER, H.J., LEDDA, F. & ZICHE, M. (1996). Nitric oxide mediates mitogenic effect of VEGF on coronary venular endothelium. Am. J. Physiol., 270, H411-H415.
5. 1 receptor mediates the migration-promoting effect of substance P on human skin fibroblasts in culture. Naunyn-Schmiedeberg's Arch. Pharmacol., 353, 475-481.
6. SCHELLING, M.E., MEININGER, C.J., HAWKER, J.R. & GRANGER, H.J. (1988). Venular endothelial cells from bovine heart. Am. J. Physiol., 254, H1211-H1217.
7. VUKANOVIC, J. & ISAACS, J.T. (1995a). Linomide inhibits angiogenesis, growth, metastasis, and macrophage infiltration within rat prostatic cancers. Cancer Res., 55, 1499-1504.
8. VUKANOVIC, J. & ISAACS, J.T. (1995b). Human prostatic cancer cells are sensitive to programmed (apoptotic) death induced by the angiogenic agent linomide. Cancer Res., 55, 3517-3520.
9. VUKANOVIC, J., PASSANITI, A., HIRATA, T., TRAYSTMAN, R.J., HARTLEY-ASP, B. & ISAACS, J.T. (1993). Antiangiogenic effects of the quinoline-3-carboxamide linomide. Cancer Res., 53, 1833-1837.